A. Rendon

发表

Global Phylogeny of Mycobacterium tuberculosis Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set

Jonathan Crabtree, Manzour Hernando Hazbón, Nalin Rastogi, 2006, Journal of bacteriology.

[Current panorama in the diagnosis of cutaneous tuberculosis].

J. Ocampo-Candiani, A. Rendon, J. Almaguer-Chávez, 2009, Actas dermo-sifiliograficas.

Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.

S. Esposito, Simon Tiberi, G. Migliori, 2017, Journal of thoracic disease.

Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test

R. Rodríguez‐Gutiérrez, A. Rendon, J. González‐González, 2016, International journal of endocrinology.

In Vitro Activity of a New Isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and Other Mycobacteria

J. Ocampo-Candiani, M. Pucci, A. Rendon, 2010, Antimicrobial Agents and Chemotherapy.

South to North Migration Patterns of Tuberculosis Patients Diagnosed in the Mexican Border with Texas

M. Yotebieng, J. Torrelles, A. Rendon, 2021, Journal of Immigrant and Minority Health.

In Vitro Susceptibility of Mycobacterium tuberculosis Clinical Isolates to Garenoxacin and DA-7867

J. Ocampo-Candiani, A. Rendon, K. Blackwood, 2005, Antimicrobial Agents and Chemotherapy.

Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis

A. Rendon, A. Rosas-Taraco, M. Salinas-Carmona, 2012, BMC Infectious Diseases.

International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis

G. Migliori, A. Rendon, R. Centis, 2019, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

Genetic Diversity of Mycobacterium tuberculosis Isolates From an Amerindian Population in Chiapas, México

J. Ocampo-Candiani, F. Quinn, A. Rendon, 2022, Frontiers in Cellular and Infection Microbiology.

Comparative Mycobacterium tuberculosis Spoligotype Distribution in Mexico

J. Ocampo-Candiani, A. Rendon, L. G. Rivera-Morales, 2014, Journal of Clinical Microbiology.

Mycobacterium tuberculosis Spoligotypes in Monterrey, Mexico

Nalin Rastogi, J. Ocampo-Candiani, K. Kremer, 2009, Journal of Clinical Microbiology.

Tuberculosis Phenotypic and Genotypic Drug Susceptibility Testing and Immunodiagnostics: A Review

M. Yotebieng, Shu-Hua Wang, J. Torrelles, 2022, Frontiers in Immunology.

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?

A. Spanevello, R. Perez-Padilla, F. Mello, 2016, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

Cortisol and perceived stress are associated with cytokines levels in patients infected with influenza B virus.

G. Muñoz-Maldonado, A. Rendon, A. Rosas-Taraco, 2020, Cytokine.

In Vitro Activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis

J. Ocampo-Candiani, A. Rendon, Victor M. Velazquez-Moreno, 2006, Antimicrobial Agents and Chemotherapy.

TGF- b Blood Levels Distinguish Between Inﬂuenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired Pneumonia

E. Rendón-Ramírez, A. Rendon, A. Rosas-Taraco, 2015 .

Relevant Cytokines in the Management of Community-Acquired Pneumonia

E. Rendón-Ramírez, A. Rendon, A. Rosas-Taraco, 2016, Current Infectious Disease Reports.

Breaking the barriers: Migrants and tuberculosis.

A. Matteelli, G. Sotgiu, M. Dara, 2017, Presse medicale.

Human Eosinophils Reduce Viral Titer, Secrete IL-8, and Increase RIG-I Expression in Response to Influenza A H1N1 pdm09.

E. Salinas, A. Rendon, A. Rosas-Taraco, 2021, Viral immunology.

Chronic obstructive pulmonary disease case finding in Mexico in an at-risk population.

R. Laniado-Laborín, A. Rendon, O. Bauerle, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

High altitude and chronic obstructive pulmonary disease prevalence: a casual or causal correlation?

R. Laniado-Laborín, A. Rendon, O. Bauerle, 2012, Archivos de bronconeumologia.

Subutilization of COPD Guidelines in Primary Care

R. Laniado-Laborín, A. Rendon, O. Bauerle, 2013, Journal of primary care & community health.

CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis.

Guillermo Caballero-Olín, A. Rendon, A. Rosas-Taraco, 2007, The Journal of infectious diseases.

Is It Ever Safe To Stop Azole Therapy for Coccidioides immitis Meningitis?

J. Galgiani, D. Stevens, J. Graybill, 1996, Annals of Internal Medicine.

Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020

G. Ippolito, A. Spanevello, D. Buonsenso, 2020, Emerging infectious diseases.

Coccidioidomycosis in Latin America.

R. Laniado-Laborín, A. Rendon, E. Arathoon, 2019, Medical mycology.

Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis.

J. Galgiani, D. Stevens, G. Cloud, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Accuracy of the tuberculin skin test for diagnosis of latent tuberculosis in population with high coverage of Bacillus Calmette–Guérin vaccination

Pablo Cruz-Hervert, L. García-García, A. Rendon, 2020, Revista M�dica del Hospital General de M�xico.

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

J. Perfect, J. Vazquez, F. Queiroz-Telles, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study

R. Duarte, D. Buonsenso, G. Sotgiu, 2022, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function

Evgeny V. Morozov, V. G. Abramov, T. Welte, 2022, Infection.

MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.

A. Garcia-Basteiro, Alimuddin Zumla, R. Duarte, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Eliminating tuberculosis in Latin America: making it the point

R. Duarte, A. Kritski, G. Migliori, 2018, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

Roadmap for tuberculosis elimination in Latin American and Caribbean countries: a strategic alliance

M. D. Granado, R. Duarte, G. Migliori, 2016, European Respiratory Journal.

Posaconazole therapy for chronic refractory coccidioidomycosis.

D. Stevens, J. Graybill, A. Catanzaro, 2007, Chest.

Constrictive pericarditis and recurrent mycetoma due to Nocardia brasiliensis in non-immunocompromised patient

K. Eisenach, A. Rendon, M. Salinas-Carmona, 1997 .

The cursed duet today: Tuberculosis and HIV-coinfection.

Alimuddin Zumla, E. Pontali, Ananna Rahman, 2017, Presse medicale.

Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study

R. Duarte, D. Buonsenso, G. Sotgiu, 2021, European Respiratory Journal.

Dot Blot Assay for Detection of Antidiacyltrehalose Antibodies in Tuberculous Patients

A. Rendon, A. Laszlo, V. Handzel, 1999, Clinical Diagnostic Laboratory Immunology.

WHO strategies for the management of drug-resistant tuberculosis.

G. Migliori, A. Rendon, R. Centis, 2017, Archivos de bronconeumologia.

Rapid Diagnosis of XDR and Pre-XDR TB: A Systematic Review of Available Tools.

G. Sotgiu, Simon Tiberi, J. Alffenaar, 2022, Archivos de bronconeumologia.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

A. Spanevello, R. Duarte, D. Visca, 2019, European Respiratory Journal.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

A. Spanevello, R. Duarte, E. Martínez Robles, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Immune Response to Nocardia brasiliensis Extracellular Antigens in Patients with Mycetoma

J. Ocampo-Candiani, A. Rendon, M. Salinas-Carmona, 2008, Mycopathologia.

Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives.

Simon Tiberi, G. Migliori, A. Rendon, 2016, Journal of thoracic disease.

The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines

E. Pontali, G. Migliori, A. Piubello, 2019, European Respiratory Journal.

Tuberculosis elimination: where are we now?

A. Spanevello, D. Visca, A. Matteelli, 2018, European Respiratory Review.

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis

Alimuddin Zumla, R. Duarte, M. Gaga, 2018, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

Expression of CDllc in blood monocytes as biomarker for favorable response to antituberculosis treatment.

Guillermo Caballero-Olín, A. Rendon, A. Rosas-Taraco, 2009, Archives of medical research.

The Effects of Socioeconomic Status, Clinical Factors, and Genetic Ancestry on Pulmonary Tuberculosis Disease in Northeastern Mexico

J. Long, Jack D Baker, B. Young, 2014, PloS one.

Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation.

J. Esquivel-Valerio, J. Rodríguez-Amado, M. Garza-Elizondo, 2010, Clinical and experimental rheumatology.

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

Sudhir R Parikh, I. Pavord, Wei Zhang, 2023, Respiratory Research.

Social and clinical predictors of drug-resistant tuberculosis in a public hospital, Monterrey, Mexico.

J. Long, A. Handal, Jack D Baker, 2014, Annals of epidemiology.

South to North Migration Patterns of Tuberculosis Patients Diagnosed in the Mexican Border with Texas

M. Yotebieng, J. Torrelles, A. Rendon, 2021, Journal of Immigrant and Minority Health.

Immunological Characterization of Novel Secreted Antigens of Mycobacterium tuberculosis

P. Bifani, M. Gennaro, J. Spencer, 2005, Scandinavian journal of immunology.

Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico.

E. Graviss, M. D. Cave, S. Ramaswamy, 2004, Journal of medical microbiology.

TGF-β Blood Levels Distinguish Between Influenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired Pneumonia.

E. Rendón-Ramírez, A. Rendon, A. Rosas-Taraco, 2015, Viral immunology.

Possible association of rare polymorphism in the ABCB1 gene with rifampin and ethambutol drug-resistant tuberculosis.

José Alberto Rodríguez-Castillo, A. Rendon, A. Rosas-Taraco, 2015, Tuberculosis.

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study

R. Duarte, G. Sotgiu, Simon Tiberi, 2023, International Journal of Infectious Diseases.

Non-tuberculous mycobacterial pulmonary infections

J. Chalmers, A. Rendon, A. C. Carvalho, 2018 .

A clinic-based molecular epidemiologic study of tuberculosis in Monterrey, Mexico.

J. Bates, K. Ijaz, K. Eisenach, 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

HIGH COPD PREVALENCE IN MEXICO: A PREVALENCE STUDY

R. Laniado-Laborín, A. Rendon, O. Bauerle, 2009 .

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.

A. Spanevello, R. Duarte, E. Martínez Robles, 2021, Pulmonology.

Global TB Network: working together to eliminate tuberculosis

S. Esposito, G. Sotgiu, J. Alffenaar, 2018, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

Sudhir R Parikh, I. Pavord, M. Zhang, 2023, Respiratory Research.

Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis

J. Tapia, C. Rodríguez-Padilla, F. Quinn, 2017, PloS one.

Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network

K. Dheda, E. Pontali, A. Matteelli, 2021, Antibiotics.